Kidney Diseases
Nephrology·MeSH: Kidney Diseases
Prevalence
16035.4 / 100K
Incidence
601.9 / 100K/yr
8 drugs in development·6 companies·10 clinical trials
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| zigakibart | Novartis AG (NVS) |
Phase 2(5)
Phase 1(1)
| Drug | Company |
|---|---|
| disc-0974 | Disc Medicine, Inc. (IRON) |
Phase 4(1)
Compare drugs
Frequently asked questions
How many drugs are in development for Kidney Diseases?
BioSniper tracks 8 drugs in development for Kidney Diseases across 6 companies.
How many clinical trials target Kidney Diseases?
There are 10 clinical trials targeting Kidney Diseases tracked by BioSniper.
What is the prevalence of Kidney Diseases?
The estimated prevalence of Kidney Diseases is approximately 16035.4 per 100,000 population.
Deep-dive into Kidney Diseases
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis